NCT04718155View on ClinicalTrials.gov

Could Early Atorvastatin Offer Anti Inflammatory Effects Upon Brain in Traumatic Head Injury?

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

June 1, 2022

Conditions
Traumatic Brain Injury
Interventions
DRUG

Atorvastatin

will receive 40 mg atrorvastatin 2 days

OTHER

placebo

will receive 40 mg placebo 2 days

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04718155 - Could Early Atorvastatin Offer Anti Inflammatory Effects Upon Brain in Traumatic Head Injury? | Biotech Hunter | Biotech Hunter